Newish Technology (beijing) Co., Ltd.

This phase 2 trial tests a DNA vaccine called NWRD06 in 30 people with a specific type of liver cancer (GPC3-positive) who have had surgery to remove their tumors. The vaccine is given as a shot followed by a mild electric pulse to help it enter cells. The goal is to see if it ca…